Total words: 3736 | 2-word phrases: 969 | 3-word phrases: 1123 | 4-word phrases: 1190
Title | Try to keep the title under 60 characters (96 characters) A COPD or Asthma Treatment | TRELEGY ELLIPTA (fluticasone furoate, umeclidinium, and vilanterol) |
Description | Try to keep the meta description between 50 - 160 characters (127 characters) Learn about TRELEGY (fluticasone furoate, umeclidinium, and vilanterol), a once-daily maintenance treatment for COPD or asthma. |
Keywords | Meta keywords are not recommended anymore (0 characters) |
H1 | H1 tag on the page (14 characters) COPD or ASTHMA |
# | Keyword | H1 | Title | Des | Volume | Position | Suggest | Frequency | Density |
---|---|---|---|---|---|---|---|---|---|
1 | trelegy | 61 | 13.44% | ||||||
2 | and | 37 | 8.15% | ||||||
3 | of | 35 | 7.71% | ||||||
4 | to | 33 | 7.27% | ||||||
5 | a | 27 | 5.95% | ||||||
6 | or | 25 | 5.51% | ||||||
7 | for | 25 | 5.51% | ||||||
8 | the | 24 | 5.29% | ||||||
9 | your | 23 | 5.07% | ||||||
10 | is | 23 | 5.07% |
# | URL | Whois | Check |
---|---|---|---|
1 | https://gskpro.com/content/dam/global/hcpportal/en_US/therapy-area/respiratory/pdf/TRELEGY-datos-importantes.pdf | Whois | gskpro.com |
2 | https://gskpro.com/content/dam/global/hcpportal/en_US/therapy-area/respiratory/pdf/TRELEGY-ELLIPTA-IFU-SP.pdf | Whois | gskpro.com |
3 | https://gskpro.com/content/dam/global/hcpportal/en_US/therapy-area/respiratory/pdf/asthma-control-test-sp.pdf | Whois | gskpro.com |
4 | https://gskpro.com/content/dam/global/hcpportal/en_US/Prescribing_Information/Trelegy_Ellipta/pdf/TRELEGY-ELLIPTA-PI-PIL-IFU.PDF | Whois | gskpro.com |
5 | https://gskpro.com/content/dam/global/hcpportal/en_US/Prescribing_Information/Trelegy_Ellipta/pdf/TRELEGY-ELLIPTA-PI-PIL-IFU.PDF#page=47 | Whois | gskpro.com |
6 | https://gskpro.com/content/dam/global/hcpportal/en_US/therapy-area/respiratory/pdf/TRELEGY-datos-importantes.pdf | Whois | gskpro.com |
7 | https://gskpro.com/content/dam/global/hcpportal/en_US/therapy-area/respiratory/pdf/TRELEGY-ELLIPTA-IFU-SP.pdf | Whois | gskpro.com |
8 | https://gskpro.com/content/dam/global/hcpportal/en_US/therapy-area/respiratory/pdf/asthma-control-test-sp.pdf | Whois | gskpro.com |
9 | https://gskpro.com/content/dam/global/hcpportal/en_US/Prescribing_Information/Trelegy_Ellipta/pdf/TRELEGY-ELLIPTA-PI-PIL-IFU.PDF | Whois | gskpro.com |
10 | https://gskpro.com/content/dam/global/hcpportal/en_US/Prescribing_Information/Trelegy_Ellipta/pdf/TRELEGY-ELLIPTA-PI-PIL-IFU.PDF#page=47 | Whois | gskpro.com |
11 | https://www.gsksource.com/pharma/content/gsk/source/us/en/brands/trelegy/pi/home.html | Whois | gsksource.com |
12 | https://www.gsksource.com/pharma/content/gsk/source/us/en/brands/trelegy/pi/home.html | Whois | gsksource.com |
13 | http://www.fda.gov/medwatch | Whois | fda.gov |
14 | https://www.gskforyou.com | Whois | gskforyou.com |
15 | https://www.gskforyou.com/ | Whois | gskforyou.com |
16 | https://us.gsk.com/en-us/legal-notices/ | Whois | gsk.com |
17 | https://privacy.gsk.com/en-us/ | Whois | gsk.com |
18 | https://privacy.gsk.com/en-us/privacy-notice/consumer-health-privacy | Whois | gsk.com |
19 | https://us.gsk.com/en-us/about-our-ads/ | Whois | gsk.com |
20 | https://www.gskforyou.com/ | Whois | gskforyou.com |
21 | https://contactus.gsk.com/ | Whois | gsk.com |
22 | https://contactus.gsk.com/patient-support/unsubscribe/ | Whois | gsk.com |
23 | https://www.youtube.com/channel/UC8tQ8NY63lsponzmGI6N5_A | Whois | youtube.com |
24 | https://www.facebook.com/TRELEGY-fluticasone-furoate-umeclidinium-and-vilanterol-inhalation-powder-410866192669122/ | Whois | facebook.com |
25 | https://us.gsk.com/ | Whois | gsk.com |